BDX Q1 2025 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.2B+9.8% YoY

Gross Profit

$2.2B43.2% margin

Operating Income

$453M8.8% margin

Net Income

$303M5.9% margin

EPS (Diluted)

$1.04

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

$693M

Free Cash Flow

$588M

Stock-Based Comp.

$90M

Balance Sheet

Total Assets

$54.7B

Total Liabilities

$29.5B

Stockholders' Equity

$25.2B

Cash & Equivalents

$711M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.2B	$4.7B	+9.8%
Gross Profit	$2.2B	$2.0B	+10.3%
Operating Income	$453M	$439M	+3.2%
Net Income	$303M	$281M	+7.8%

Revenue Segments

Medical

$2.6B51%

Life Sciences

$1.3B25%

Interventional

$1.3B24%

Geographic Segments

UNITED STATES

$3.1B60%

Non-US

$2.1B40%